SAT022 A Mechanism Of Resistance To Novel Inhibitors Of The N-Terminal Domain Of Androgen Receptor

Disclosure: J. Setiawan: None. N.R. Mawji: None. A.H. Tien: None. R.J. Andersen: Stock Owner; Self; ESSA Pharma. M.D. Sadar: Stock Owner; Self; ESSA Pharma. Background: Androgen receptor (AR) is a steroid hormone receptor and a major therapeutic target in prostate cancer. Antiandrogen therapies dire...

Descripción completa

Detalles Bibliográficos
Autores principales: Setiawan, Josie, Mawji, Nasrin R, Tien, Amy H, Andersen, Raymond J, Sadar, Marianne D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Steroid Hormones, Nuclear Receptors And Coregulators
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555213/
http://dx.doi.org/10.1210/jendso/bvad114.1760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555213/
http://dx.doi.org/10.1210/jendso/bvad114.1760

Ejemplares similares